ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Neurological Surgery

Top Neurological Surgery Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SANJOY SUNDARESAN M.D.

Neurological Surgery

7,181

$405K

460
111 are 65+

53%
patients receiving schedule two controlled substances

Avg: 3%

86%
patients receiving schedule three controlled substances

Avg: 56%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

9%
prescriptions for brand name drugs

Avg: 6%

$56
Average prescription price

Avg: $52

AMIR TORABI M.D.

Neurological Surgery

4,046

$479K

453
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 56%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

19%
prescriptions for brand name drugs

Avg: 6%

$118
Average prescription price

Avg: $52

CHRISTOPHER VANDERZANT DO

Neurological Surgery

3,296

$736K

372
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 56%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

27%
prescriptions for brand name drugs

Avg: 6%

$223
Average prescription price

Avg: $52

MATHEW ALEXANDER MD

Neurological Surgery

2,870

$297K

611
371 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

44%
patients receiving schedule three controlled substances

Avg: 56%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

27%
prescriptions for brand name drugs

Avg: 6%

$104
Average prescription price

Avg: $52

RAUL SEPULVEDA MD

Neurological Surgery

2,005

$75K

197
132 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

75%
patients receiving schedule three controlled substances

Avg: 56%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

7%
prescriptions for brand name drugs

Avg: 6%

$37
Average prescription price

Avg: $52

SYED HUSSAIN M.D.

Neurological Surgery

1,928

$32.8K

416
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

37%
patients receiving schedule three controlled substances

Avg: 56%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

3%
prescriptions for brand name drugs

Avg: 6%

$17
Average prescription price

Avg: $52

MOHAMED BECK M.D

Neurological Surgery

1,706

$122K

327
95 are 65+

43%
patients receiving schedule two controlled substances

Avg: 3%

60%
patients receiving schedule three controlled substances

Avg: 56%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

13%
prescriptions for brand name drugs

Avg: 6%

$71
Average prescription price

Avg: $52

ROBERT LEGRAND MD

Neurological Surgery

1,620

$31.2K

150
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

79%
patients receiving schedule three controlled substances

Avg: 56%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

2%
prescriptions for brand name drugs

Avg: 6%

$19
Average prescription price

Avg: $52

DAVID TOMASZEK M.D.

Neurological Surgery

1,541

$108K

113
37 are 65+

35%
patients receiving schedule two controlled substances

Avg: 3%

68%
patients receiving schedule three controlled substances

Avg: 56%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

10%
prescriptions for brand name drugs

Avg: 6%

$70
Average prescription price

Avg: $52

WARREN NEELY M.D.

Neurological Surgery

1,408

$44.5K

265
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 56%

28%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

6%
prescriptions for brand name drugs

Avg: 6%

$32
Average prescription price

Avg: $52

LUIS DUARTE MD

Neurological Surgery

1,377

$31.2K

338
200 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

76%
patients receiving schedule three controlled substances

Avg: 56%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

4%
prescriptions for brand name drugs

Avg: 6%

$23
Average prescription price

Avg: $52

MASAKI OISHI MD

Neurological Surgery

964

$19.7K

132
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

80%
patients receiving schedule three controlled substances

Avg: 56%

19%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

0%
prescriptions for brand name drugs

Avg: 6%

$20
Average prescription price

Avg: $52

THOMAS KINGMAN M.D.

Neurological Surgery

878

$38.4K

139
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

36%
patients receiving schedule three controlled substances

Avg: 56%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

11%
prescriptions for brand name drugs

Avg: 6%

$44
Average prescription price

Avg: $52

SERGIO PACHECO M.D.

Neurological Surgery

867

$13.4K

109
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 56%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

4%
prescriptions for brand name drugs

Avg: 6%

$15
Average prescription price

Avg: $52

GERARDO ZAVALA MD

Neurological Surgery

858

$19.8K

215
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

47%
patients receiving schedule three controlled substances

Avg: 56%

30%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

5%
prescriptions for brand name drugs

Avg: 6%

$23
Average prescription price

Avg: $52

MADHAVAN PISHARODI M.D.

Neurological Surgery

815

$53.6K

153
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

47%
patients receiving schedule three controlled substances

Avg: 56%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

15%
prescriptions for brand name drugs

Avg: 6%

$66
Average prescription price

Avg: $52

JOSE DONES M.D.

Neurological Surgery

815

$18.9K

292
185 are 65+

15%
patients receiving schedule two controlled substances

Avg: 3%

67%
patients receiving schedule three controlled substances

Avg: 56%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

3%
prescriptions for brand name drugs

Avg: 6%

$23
Average prescription price

Avg: $52

HAROLD HAMILTON M.D.

Neurological Surgery

813

$27.3K

186
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

51%
patients receiving schedule three controlled substances

Avg: 56%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

7%
prescriptions for brand name drugs

Avg: 6%

$34
Average prescription price

Avg: $52

ARNULFO GARZA-VALE M.D.

Neurological Surgery

756

$39.3K

100
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

40%
patients receiving schedule three controlled substances

Avg: 56%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

12%
prescriptions for brand name drugs

Avg: 6%

$52
Average prescription price

Avg: $52

RAFAEL PARRA M.D.

Neurological Surgery

752

$10.4K

217
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

31%
patients receiving schedule three controlled substances

Avg: 56%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

3%
prescriptions for brand name drugs

Avg: 6%

$14
Average prescription price

Avg: $52

THOMAS MIMS MD

Neurological Surgery

748

$30.1K

77
51 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

68%
patients receiving schedule three controlled substances

Avg: 56%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

14%
prescriptions for brand name drugs

Avg: 6%

$40
Average prescription price

Avg: $52

SHANKER SUNDRANI M.D.

Neurological Surgery

746

$33K

132
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

30%
patients receiving schedule three controlled substances

Avg: 56%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

9%
prescriptions for brand name drugs

Avg: 6%

$44
Average prescription price

Avg: $52

JACOB ROSENSTEIN MD

Neurological Surgery

715

$34.6K

76
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

34%
patients receiving schedule three controlled substances

Avg: 56%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

16%
prescriptions for brand name drugs

Avg: 6%

$48
Average prescription price

Avg: $52

NEAL HAYNES M.D.

Neurological Surgery

693

$35.7K

89
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

74%
patients receiving schedule three controlled substances

Avg: 56%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

7%
prescriptions for brand name drugs

Avg: 6%

$51
Average prescription price

Avg: $52

JAMES KAUFMAN MD

Neurological Surgery

682

$10.4K

58
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

90%
patients receiving schedule three controlled substances

Avg: 56%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 8%

5%
prescriptions for brand name drugs

Avg: 6%

$15
Average prescription price

Avg: $52

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank